The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I clinical trial of temozolomide and methoxyamine (TRC-102) in patients with advanced solid tumors.
 
Jennifer Rachel Eads
Consulting or Advisory Role - Novartis
Research Funding - Novartis
Travel, Accommodations, Expenses - Amgen
 
Smitha S. Krishnamurthi
Research Funding - Nektar
 
Joel N. Saltzman
Stock and Other Ownership Interests - Foundation Medicine; novartis; Roche
 
Neal J. Meropol
Consulting or Advisory Role - BioMotiv
Patents, Royalties, Other Intellectual Property - US Patent (20020031515): Methods of therapy for cancers characterized by over expression of the HER2 receptor protein
 
Joseph A. Bokar
No Relationships to Disclose
 
Joseph Gibbons
Travel, Accommodations, Expenses - Amgen; Janssen
 
Henry B. Koon
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Bristol-Myers Squibb (Inst)
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb (Inst)
 
Neelesh Sharma
Research Funding - Incuron (Inst)
 
Panayiotis Savvides
No Relationships to Disclose
 
John Pink
No Relationships to Disclose
 
Yan Xu
No Relationships to Disclose
 
Jan Hendrik Beumer
Employment - GlaxoSmithKline (I)
Stock and Other Ownership Interests - GlaxoSmithKline (I)
Consulting or Advisory Role - BTG; Saladax Biomedical
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); Millennium (Inst); Novartis (Inst); Saladax Biomedical (Inst); Spectrum Pharmaceuticals (Inst); Taiho Pharmaceutical (Inst)
Patents, Royalties, Other Intellectual Property - Sulphoraphane for melanoma chemoprevention (Inst)
 
Pingfu Fu
No Relationships to Disclose
 
Kristi Beatty
Honoraria - Pfizer
 
Donna Kane
No Relationships to Disclose
 
Mary Beth Rodal
No Relationships to Disclose
 
Julianne Czalkiewicz
No Relationships to Disclose
 
John Riendeau
No Relationships to Disclose
 
Stanton L. Gerson
Stock and Other Ownership Interests - Amgen; Biogen; Incyte; Johnson & Johnson; Novartis; Osiris Medical; Pfizer
Patents, Royalties, Other Intellectual Property - Lentigen; Osiris Medical; TRACON Pharma
Other Relationship - CPR IT Reviews
 
Afshin Dowlati
No Relationships to Disclose